Current Status and Global Application of Immune Checkpoint Inhibitor Therapy in Endometrial Cancer

Download All

Gain insights from international experts on current best practice and emerging strategies for immune checkpoint inhibition in patients with endometrial cancer.

This educational program is intended for clinicians practicing medicine outside of the United States.

person default
Maria-Pilar Barretina-Ginesta, MD
Domenica Lorusso, MD, PhD

ClinicalThought

Is immunotherapy suitable/appropriate for the treatment of endometrial cancer? Read my thoughts on why genetic profiling of endometrial cancer is important and which patients may benefit from single-agent immunotherapy or immunotherapy-based combinations.

This educational activity is intended for clinicians practicing medicine outside of the United States.

Domenica Lorusso, MD, PhD Released: February 25, 2021

Read my thoughts to learn how the management of endometrial cancer continues to evolve with the use of immunotherapies as single agents or in combinations.

person default Maria-Pilar Barretina-Ginesta, MD Released: June 28, 2021

Translated ClinicalThought

Leggi il commento Dr. Domenica Lorusso, in italiano, sugli ultimi dati clinici e sullo stato attuale dell'immunoterapia per la gestione del cancro dell'endometrio.

Domenica Lorusso, MD, PhD Released: April 29, 2021

阅读 Domenica Lorusso 博士有关子宫内膜癌管理的最新临床数据和免疫疗法现状的中文版评论。

This educational activity is intended for clinicians practicing medicine outside of the United States.

Domenica Lorusso, MD, PhD Released: March 26, 2021

Veuillez lire le commentaire du Dr Domenica Lorusso, en français, sur les dernières données cliniques et l'état actuel de l'immunothérapie pour la gestion du cancer de l'endomètre.

This educational activity is intended for clinicians practicing medicine outside of the United States.

Domenica Lorusso, MD, PhD Released: March 31, 2021

子宮内膜がんの管理についての、最新の臨床データと現在の免疫療法の状況については、Dr. Domenica Lorussoのコメント(中国語)をお読みください。

This educational activity is intended for clinicians practicing medicine outside of the United States.

Domenica Lorusso, MD, PhD Released: March 30, 2021

Lea el comentario de la Dra. Domenica Lorusso, en español, sobre los datos clínicos más recientes y el estado actual de la inmunoterapia para el tratamiento del cáncer de endometrio.

Domenica Lorusso, MD, PhD Released: May 10, 2021

阅读我的想法,了解随着免疫疗法作为单一药物或联合药物使用,子宫内膜癌的管理是如何继续发展的。

person default Maria-Pilar Barretina-Ginesta, MD Released: July 29, 2021

Je vous invite à lire mes réflexions pour savoir comment la prise en charge du cancer de l'endomètre continue d'évoluer grâce à l'utilisation d'immunothérapies en mono-thérapie ou en association.

person default Maria-Pilar Barretina-Ginesta, MD Released: July 27, 2021

Leggete le mie opinioni per scoprire come la gestione del tumore endometriale continua ad evolversi con l'uso di immunoterapie come agenti singoli o in combinazioni.

person default Maria-Pilar Barretina-Ginesta, MD Released: July 28, 2021

免疫療法を単剤療法として、または併用療法として使用することにより、子宮内膜がんの処置がどのように進化を続けているかを学ぶために、私の考えをお読みください。

person default Maria-Pilar Barretina-Ginesta, MD Released: July 28, 2021

Consulte mis artículos sobre cómo el manejo del cáncer de endometrio continúa evolucionando con el uso de inmunoterapias como agentes únicos o en combinaciones.

person default Maria-Pilar Barretina-Ginesta, MD Released: July 29, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue